News | Heart Failure | September 29, 2015

American Heart Association Launches National Initiative to Combat Heart Failure

New association report projects nearly 40 percent diagnosis increase, doubling of associated costs within 15 years

American Heart Association, AHA, heart failure, HF, Rise Above Heart Failure initiative, report

September 29, 2015 — A new report from the American Heart Association (AHA) projects that the number of Americans diagnosed with heart failure (HF) will increase nearly 40 percent within 15 years, and the associated costs will nearly double. With these numbers in mind, the AHA announced the launch of the national Rise Above Heart Failure initiative.  

The goals for the initiative are to reduce HF hospitalizations by 10 percent and increase awareness and understanding of the condition by 10 percent by 2020.

HF, also known as congestive heart failure, is a chronic, progressive condition in which the heart is unable to pump enough blood to meet the body's needs. It is one of the most common heart diseases in the United States, with more than 870,000 new cases reported annually and one in nine deaths including HF as a contributing cause. There are ways to manage and treat the condition, yet about half of those with HF die within five years of being diagnosed.

According to the association's 2015 Impact of Heart Failure Report, by 2030 the number of people diagnosed with HF is expected to increase from about 6 million to nearly 8 million. Total medical costs to treat the condition are projected to increase from $14.3 billion in 2015 to $29.2 billion in 2030. Additionally, indirect costs of HF — including work loss, household productivity losses and premature mortality losses — are projected to increase from $8.2 billion in 2015 to $12.3 billion in 2030.

"Heart failure is one of the most misunderstood health issues facing our country today, yet its impact is undeniable," said Nancy Brown, chief executive officer of the American Heart Association. "We've made significant progress in many areas of cardiovascular disease, and now more than ever, it's important to set this target on heart failure and activate together to help all Americans rise above this potentially deadly condition."

Through Rise Above Heart Failure, nationally supported by Novartis Pharmaceuticals Corp., the AHA plans to:

  • Increase awareness of heart failure and its symptoms and treatments;
  • Promote a heart failure dialogue and inspire people living with heart failure and their loved ones to take a more active role in their care;
  • Encourage all people to make small changes that can lead to healthier lifestyles; and
  • Bring together an alliance of influential organizations to collectively support the goal of reducing the impact of heart failure.

"By having clear goals, we can implement strategies and programs that can help change the trajectory of heart failure," said Clyde W. Yancy, M.D., a past president of the American Heart Association and chief of cardiology and Magerstadt Professor at Northwestern University Feinberg School of Medicine in Chicago. "None of us can do this alone, it will take a commitment of individuals and public and private organizations working together to rise above the staggering impact of heart failure."

Yancy moderated a forum of public health leaders meeting at the National Press Club in Washington, D.C., to present the findings of the AHA report and announce the formation of the Rise Above Heart Failure Alliance. The alliance will include key thought leaders in healthcare, patient advocacy, industry and government who will come together to further assess the current burden of HF. The alliance will also develop strategies to address the issue, such as policy changes, healthcare system improvements, and patient awareness and empowerment initiatives.

Panelists at the National Press Club event included:

  • Janet Wright, M.D., executive director, Million Hearts, Centers for Medicare & Medicaid Services;
  • Michele Blair, chief executive officer, Heart Failure Society of America; and
  • Ryan Olohan, national industry director, healthcare, Google

For more information: www.riseabovehf.org

Related Content

Heart Failure Market to Surpass $16 Billion by 2026
News | Heart Failure| September 19, 2017
The heart failure space across the seven key markets of the U.S., France, Germany, Italy, Spain, the U.K. and Japan is...
Heart Failure Patients, Clinicians Have Differing Perceptions of Risk Level
News | Heart Failure| September 06, 2017
September 6, 2017 — Physicians identified a majority of patients with advanced...
Israeli Hospital Completes First Implant of CORolla Heart Failure Device
News | Heart Failure| September 05, 2017
Rambam Hospital in Haifa, Israel, recently became the first to use the CORolla device from Israeli start-up company...
Abbott Receives FDA Approval for HeartMate 3 Left Ventricular Assist System
Technology | Ventricular Assist Devices (VAD)| August 29, 2017
Abbott announced it has received U.S. Food and Drug Administration (FDA) approval for its Full MagLev HeartMate 3 Left...
Sponsored Content | Videos | Cardiovascular Ultrasound| August 28, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
Registry Identifies Early Onset of Heart Failure and Lack of Defibrillators in Asia
News | Heart Failure| August 03, 2017
August 3, 2017 — The Asian Pacific Society of Cardiology (ASPC) held its first-ever late-breaking...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Wearable monitors create patient generated health data, PGHD, that can help prevent acute care episodes in heart failure.

Wearable monitoring devices may offer a new tool to help prevent acute care episodes in heart failure.

Feature | Heart Failure| July 25, 2017 | Lola Koktysh
Despite their best efforts, many patients tend to develop heart failure after an acute event (e.g., a heart attack or
Overlay Init